MedicaMetrix, Inc/DE
OperatingHealthcare · Lowell, MA
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Oct 19, 2021| Class | Outstanding | Votes / share | Share of total | Liquidation | Last price |
|---|---|---|---|---|---|
| Series B Preferred Stockpreferred(as of Jul 31, 2021) | 2,727,273 | — | 15.6% | paid 1st | — |
| Series A Preferred Stockpreferred(as of Jul 31, 2021) | 1,000,000 | 1 | 5.73% | paid 2nd | — |
| Common Stock | 10,000,000 | 1 | 57.3% | paid 3rd | — |
| Preferred Stockpreferred | 3,727,723 | — | 21.4% | — | $0.50Jul 2021 |
| Total | 17,454,996 | 100% |
Shares outstanding over timein today's share terms
Principal holders% as the filing states it, Oct 7, 2021
- Janus Henderson Research Fund2,727,273 Series B Preferred Stock100.0%of Series B Preferred
- Satish Vankayalapati3,500,000 Common Stock35.0%of
- Robert Rudelius3,465,000 Common Stock34.7%of
- Jeanne Rudelius Trust250,000 Series A Preferred Stock25.0%of Series A Preferred
- John Mega200,000 Series A Preferred Stock20.0%of Series A Preferred
- Noble Ventures, LLC1,500,000 Common Stock15.0%of
- William and Jacqueline Rudelius150,000 Series A Preferred Stock15.0%of Series A Preferred
- UrbanX Global Investors, LLC1,150,000 Common Stock11.5%of
- Steven Hartley100,000 Series A Preferred Stock10.0%of Series A Preferred
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 16 filings on EDGAR- Form 253G2Oct 26, 20220001493152-22-029559EDGAR
- Form 253G2May 26, 20220001493152-22-015089EDGAR
- Form 253G2May 25, 20220001493152-22-015038EDGAR
- Form 1-SAMay 2, 20220001493152-22-011818EDGAR
- Form 1-UApr 25, 20220001493152-22-010788EDGAR
- Form 1-KMar 15, 20220001493152-22-006822EDGAR
- Form 1-UMar 3, 20220001493152-22-005866EDGAR
- Form 1-UFeb 24, 20220001493152-22-005384EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.